Remembering SeaStar Medical’s Shareholder and Cherished Friend, Jeff Goldstein
Remembering SeaStar Medical’s Shareholder and Cherished Friend, Jeff Goldstein

We are greatly saddened to announce the passing of Jeff Goldstein on June 27th, a long-serving trusted Shareholder and cherished friend of SeaStar Medical. As a committed business leader and transplant advocate, Jeff was dedicated to impacting...

Read More Patient perspectives on the state of patient access
SeaStar Medical Completes Enrollment of SCD 005 Trial to Evaluate Safety of SCD in AKI and/or ARDS Patients with COVID-19
SeaStar Medical Completes Enrollment of SCD 005 Trial to Evaluate Safety of SCD in AKI and/or ARDS Patients with COVID-19

SeaStar Medical recently completed enrollment of its SCD-005 clinical trial to demonstrate the safety of Selective Cytopheretic Device (SCD) in acute kidney injury (AKI) and acute respiratory distress syndrome (ARDS) with COVID-19 infection. This...

Read More Patient perspectives on the state of patient access